Shares of UroGen Pharma gained momentum after the U.S. FDA approved Zusduri, a therapy for recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer, prompting a flurry of bullish ...

Fifty-five attorneys general around the country have now signed on to a $7.4 billion settlement with drugmaker Purdue Pharma and its owners, the Sackler family, over the opioid crisis, officials said.

Purdue Pharma and its former owners in the notorious Sackler family will pay $7.4 billion to settle lawsuits with all 50 states, four territories and Washington, D.C.

OxyContin maker Purdue Pharma ‘s $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids will go before a judge Friday, potentially setting up votes on whether to accept it ...

The deal would be among the largest in a wave of opioid settlements. It calls for members of the Sackler family who own the company to give up ownership and to contribute up to $7 billion over time.

UroGen Pharma shares are surging this week after the company gained FDA approval for ZUSDURI. The positive clinical trial results and an analyst upgrade fueled a significant stock price increase.

By Natalie Weger Purdue Pharma received approval for the company's disclosure statement tied to its chapter 11 reorganization plan that aims to deliver more than $7.4 billion in cash to creditors ...

OxyContin maker Purdue Pharma ’s latest plan to settle thousands of lawsuits over the toll of opioids could soon move forward after every U.S. state involved agreed to it. A judge on Wednesday ...

All eligible U.S. states and territories have agreed to sign a $7.4 billion settlement with the company and family behind OxyContin, officials announced Monday.

UroGen shares traded lower Wednesday after the ODAC of the Food and Drug Administration voted against the benefit/risk of UGN-102 (mitomycin) for intravesical solution.

Purdue Pharma’s $7B opioid settlement plan could get votes from victims and cities Members of the Sackler family who own the company would pay up to $7 billion and give up ownership on the company.